AARTI PHARMALABS
Quarterly Results Analysis [Mar2024]
AARTI PHARMALABS Quarterly Results
Consolidated | Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 UnAudited |
Dec2022 UnAudited |
Sep2022 UnAudited |
Jun2022 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹506 Cr | ₹449 Cr | ₹440 Cr | ₹458 Cr | ₹485 Cr | ₹472 Cr | ₹531 Cr | ₹457 Cr |
Expenses | ₹388 Cr | ₹353 Cr | ₹352 Cr | ₹373 Cr | ₹405 Cr | ₹385 Cr | ₹441 Cr | ₹371 Cr |
Operating Income | ₹118 Cr | ₹96 Cr | ₹88 Cr | ₹85 Cr | ₹80 Cr | ₹86 Cr | ₹90 Cr | ₹86 Cr |
Other Income | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr |
Interest | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹6 Cr | ₹5 Cr | ₹6 Cr | ₹4 Cr |
Depreciation | ₹19 Cr | ₹19 Cr | ₹18 Cr | ₹17 Cr | ₹16 Cr | ₹16 Cr | ₹17 Cr | ₹14 Cr |
Profit Before Tax | ₹96 Cr | ₹74 Cr | ₹67 Cr | ₹64 Cr | ₹59 Cr | ₹65 Cr | ₹69 Cr | ₹68 Cr |
Profit After Tax | ₹65 Cr | ₹53 Cr | ₹52 Cr | ₹47 Cr | ₹43 Cr | ₹48 Cr | ₹51 Cr | ₹52 Cr |
EPS | ₹7.20 | ₹5.82 | ₹5.72 | ₹5.20 | ₹4.73 | ₹5.26 | ₹5.64 | ₹5.72 |
Industry Peers & Returns | 1W | 1M | 1Y |
AARTI PHARMALABS | 20.2% | 31.8% | 43.3% |
SUN PHARMACEUTICAL INDUSTRIES | 2% | -0.3% | 59.8% |
CIPLA | 6% | 2.8% | 50.4% |
DR REDDYS LABORATORIES | -1.3% | -2.8% | 31.5% |
ZYDUS LIFESCIENCES | 2.6% | 7.9% | 94.3% |
DIVIS LABORATORIES | 3.7% | 5.8% | 17.3% |
MANKIND PHARMA | -6.5% | -7.6% | 57% |
TORRENT PHARMACEUTICALS | 3.9% | 7.3% | 60.6% |
LUPIN | 3.2% | 3.3% | 111.9% |
AARTI PHARMALABS Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 12.72 % |
Y-o-Y | 4.27 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Mar2024 | ₹506 Cr | 12.72 | |
Dec2023 | ₹449 Cr | 2.02 | |
Sep2023 | ₹440 Cr | -4.05 | |
Jun2023 | ₹458 Cr | -5.50 | |
Mar2023 | ₹485 Cr | 2.85 | |
Dec2022 | ₹472 Cr | -11.21 | |
Sep2022 | ₹531 Cr | 16.14 | |
Jun2022 | ₹457 Cr | - |
AARTI PHARMALABS Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 22.83 % |
Y-o-Y | 46.92 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹118 Cr | 22.83 | |
Dec2023 | ₹96 Cr | 8.74 | |
Sep2023 | ₹88 Cr | 3.68 | |
Jun2023 | ₹85 Cr | 6.10 | |
Mar2023 | ₹80 Cr | -7.25 | |
Dec2022 | ₹86 Cr | -3.93 | |
Sep2022 | ₹90 Cr | 4.32 | |
Jun2022 | ₹86 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 9.01 % |
Y-o-Y | 40.93 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Mar2024 | 23.24% | 9.01 | |
Dec2023 | 21.32% | 6.55 | |
Sep2023 | 20.01% | 8.05 | |
Jun2023 | 18.52% | 12.31 | |
Mar2023 | 16.49% | -9.84 | |
Dec2022 | 18.29% | 8.22 | |
Sep2022 | 16.9% | -10.15 | |
Jun2022 | 18.81% | - |
AARTI PHARMALABS Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 23.67 % |
Y-o-Y | 52.20 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹65 Cr | 23.67 | |
Dec2023 | ₹53 Cr | 1.85 | |
Sep2023 | ₹52 Cr | 10.00 | |
Jun2023 | ₹47 Cr | 9.84 | |
Mar2023 | ₹43 Cr | -10.11 | |
Dec2022 | ₹48 Cr | -6.65 | |
Sep2022 | ₹51 Cr | -1.45 | |
Jun2022 | ₹52 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 9.69 % |
Y-o-Y | 45.93 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2024 | 12.9 % | 9.69 | |
Dec2023 | 11.76 % | -0.17 | |
Sep2023 | 11.78 % | 14.70 | |
Jun2023 | 10.27 % | 16.18 | |
Mar2023 | 8.84 % | -12.56 | |
Dec2022 | 10.11 % | 5.09 | |
Sep2022 | 9.62 % | -15.09 | |
Jun2022 | 11.33 % | - |
AARTI PHARMALABS Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 23.71 % |
Y-o-Y | 52.22 % |
Quarters | EPS | % Change | |
---|---|---|---|
Mar2024 | ₹7.2 | 23.71 | |
Dec2023 | ₹5.82 | 1.75 | |
Sep2023 | ₹5.72 | 10.00 | |
Jun2023 | ₹5.2 | 9.94 | |
Mar2023 | ₹4.73 | -10.08 | |
Dec2022 | ₹5.26 | -6.74 | |
Sep2022 | ₹5.64 | -1.40 | |
Jun2022 | ₹5.72 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD